Patent · US Active

Intranasal composition of methylcobalamin

US11331334B2 · kind B2 · utility

0Cited by
1References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 5, 2018
Grant dateMay 17, 2022
Priority date
Expiry dateMar 7, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P3/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to an intranasal composition, particularly once weekly intranasal composition comprising methylcobalamin and at least one gelling agent and a process for preparation thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.